Clinical Trials

Study Title:
A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma

For more information about the trial above please contact the study team:

Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu.

Study Coordinator, Jared Hortman, at hortman@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina